Guangdong, Guangzhou – September 25, 2019
Connexo China, a leading EQMS implementation and consulting services provider across Greater China, participated in a training and education seminar for pharmaceutical quality VPs and representatives from Sept 25 to 27 2019. The event was sponsored by the Guangdong Pharmaceutical Association (GPA), a quasi-government body that is closely affiliated with the CFDA and acts as an industry platform for academic exchanges, regulatory updates and GMP related trainings.
The seminar was organized and held in the run-up to the New Drug Registration Law which will take effect from 01 Dec 2019 and attended by pharma quality professionals from around 50 pharma companies. Connexo attended this event and showcased its QMS and LMS implementation and consulting services to the event attendees through 1-on-1 product/solution discussions and demo sessions.
As a leading QMS implementation and regulatory consulting providers across Greater China, India, and Korea, Connexo has actively engaged with industry/government counterparts and expanded its presence across the China pharma scene through its top-notch EQMS consulting and implementation expertise.
Going forward, Connexo will continue its effort for more business partnerships and broadened awareness of the importance and the value of adopting the best and right quality system among bio/pharma customers in China to ensure they advance quality practices while staying compliant.
Founded in 2009, Connexo is Asia’s leading QMS consulting and professional services company, focusing on system validation and implementation, risk analysis & assessment and compliance consulting services for life sciences companies in the regulatory industry. Connexo started out as a QMS consulting services provider and now also provides implementation and consulting services for LMS (learning management system).